SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-060199
Filing Date
2013-11-12
Accepted
2013-11-12 07:12:55
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v358927_10q.htm 10-Q 643446
2 EXHIBIT 31.1 v358927_ex31-1.htm EX-31.1 11249
3 EXHIBIT 31.2 v358927_ex31-2.htm EX-31.2 11395
4 EXHIBIT 32.1 v358927_ex32-1.htm EX-32.1 7086
5 EXHIBIT 32.2 v358927_ex32-2.htm EX-32.2 7070
  Complete submission text file 0001144204-13-060199.txt   3372907

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vtus-20130930.xml EX-101.INS 333800
7 XBRL TAXONOMY EXTENSION SCHEMA vtus-20130930.xsd EX-101.SCH 46769
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtus-20130930_cal.xml EX-101.CAL 10868
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtus-20130930_def.xml EX-101.DEF 231529
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtus-20130930_lab.xml EX-101.LAB 307429
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtus-20130930_pre.xml EX-101.PRE 255018
Mailing Address 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013
Business Address 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013 (212) 554-4388
VENTRUS BIOSCIENCES INC (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35005 | Film No.: 131206925
SIC: 2834 Pharmaceutical Preparations